P03230 (LMP1_EBVB9) Reviewed, UniProtKB/Swiss-Prot
Last modified
November 16, 2011.
Version 70.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Latent membrane protein 1 Short name=LMP-1 Alternative name(s): Protein p63 Cleaved into the following chain: | ||||
| Gene names |
| ||||
| Organism | Epstein-Barr virus (strain B95-8) (HHV-4) (Human herpesvirus 4) | ||||
| Taxonomic identifier | 10377 [NCBI] | ||||
| Taxonomic lineage | Viruses › dsDNA viruses, no RNA stage › Herpesvirales › Herpesviridae › Gammaherpesvirinae › Lymphocryptovirus | ||||
| Virus host | Homo sapiens (Human) [TaxID: 9606] |
Protein attributes
| Sequence length | 386 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Acts as a CD40 functional homolog to prevent apoptosis of infected B-lymphocytes and drive their proliferation. Functions as a constitutively active tumor necrosis factor receptor that induces the activation of several signaling pathways, including those of the nuclear factor-kappa-B family. LMP1 signaling leads to up-regulation of antiapoptotic proteins and provide growth signals in latently infected cells. It is a short-lived protein probably degraded by the proteasome. |
| Subunit structure | Interacts (via PXQXT motif) with host tumor necrosis factor receptor-associated factor (TRAF) proteins TRAF1, TRAF2, TRAF3 and TRAF5. |
| Subcellular location | |
| Domain | Two regions, C-terminal-activating region 1 (CTAR1) and CTAR2, have been identified within the cytoplasmic carboxy terminal domain that activates NF-kappa-B. Ref.7 |
| Post-translational modification | Ubiquitinated on the N-terminus. Ref.8 |
| Sequence similarities | Belongs to the herpesviridae LMP-1 family. |
Ontologies
| Keywords | |
|---|---|
| Biological process | Activation of host NF-kappa-B by virus Host-virus interaction Inhibition of host IFN-mediated response initiation by virus Inhibition of host TRAFs by virus Inhibition of host TYK2 by virus Inhibition of host innate immune response by virus Inhibition of host interferon signaling pathway by virus Viral immunoevasion |
| Cellular component | Host cell membrane Host membrane Membrane |
| Disease | Oncogene |
| Domain | Transmembrane Transmembrane helix |
| PTM | Acetylation Phosphoprotein Ubl conjugation |
| Technical term | 3D-structure Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological process | evasion by virus of host immune response Inferred from electronic annotation. Source: UniProtKB-KW transformation of host cell by virusInferred from electronic annotation. Source: InterPro |
| Cellular component | host cell plasma membrane Inferred from electronic annotation. Source: UniProtKB-SubCell integral to membraneInferred from electronic annotation. Source: UniProtKB-KW |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed | ||||||
| Chain | 2 – 386 | 385 | Latent membrane protein 1 | PRO_0000038310 | |||||
| Chain | 242 – 386 | 145 | Protein p25 | PRO_0000038311 | |||||
Regions | |||||||||
| Topological domain | 2 – 23 | 22 | Cytoplasmic | ||||||
| Transmembrane | 24 – 44 | 21 | Helical; Potential | ||||||
| Topological domain | 45 – 51 | 7 | Extracellular | ||||||
| Transmembrane | 52 – 72 | 21 | Helical; Potential | ||||||
| Topological domain | 73 – 75 | 3 | Cytoplasmic | ||||||
| Transmembrane | 76 – 96 | 21 | Helical; Potential | ||||||
| Topological domain | 97 – 106 | 10 | Extracellular | ||||||
| Transmembrane | 107 – 127 | 21 | Helical; Potential | ||||||
| Topological domain | 128 – 139 | 12 | Cytoplasmic | ||||||
| Transmembrane | 140 – 160 | 21 | Helical; Potential | ||||||
| Topological domain | 161 – 163 | 3 | Extracellular | ||||||
| Transmembrane | 164 – 184 | 21 | Helical; Potential | ||||||
| Topological domain | 185 – 386 | 202 | Cytoplasmic | ||||||
| Region | 194 – 232 | 39 | CTAR1 | ||||||
| Region | 351 – 386 | 36 | CTAR2 | ||||||
| Motif | 204 – 208 | 5 | Interaction with host TRAF proteins | ||||||
Amino acid modifications | |||||||||
| Modified residue | 2 | 1 | N-acetylglutamate; by host | ||||||
Experimental info | |||||||||
| Mutagenesis | 330 | 1 | K → R: No effect on ubiquitination and proteasomal degradation. Ref.8 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein." Fennewald S., van Santen V., Kieff E. J. Virol. 51:411-419(1984) [PubMed: 6086953] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [2] | "Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8." Hudson G.S., Farrell P.J., Barrell B.G. J. Virol. 53:528-535(1985) [PubMed: 2982035] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "DNA sequence and expression of the B95-8 Epstein-Barr virus genome." Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S., Barrell B.G. Nature 310:207-211(1984) [PubMed: 6087149] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [4] | "Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus." Baichwal V.R., Sudgen B. J. Virol. 61:866-875(1987) [PubMed: 3027413] [Abstract] Cited for: CHARACTERIZATION. |
| [5] | "Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus." Baichwal V.R., Sudgen B. Oncogene 2:461-467(1988) [PubMed: 2836780] [Abstract] Cited for: TRANSFORMING PROPERTIES. |
| [6] | "Processing of the Epstein-Barr virus-encoded latent membrane protein p63/LMP." Moorthy R., Thorley-Lawson D.A. J. Virol. 64:829-837(1990) [PubMed: 2153246] [Abstract] Cited for: PROTEOLYTIC PROCESSING. |
| [7] | "The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain." Huen D.S., Henderson S.A., Croom-Carter D., Rowe M. Oncogene 10:549-560(1995) [PubMed: 7845680] [Abstract] Cited for: DOMAIN CTAR1 AND CTAR2. |
| [8] | "Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue." Aviel S., Winberg G., Massucci M., Ciechanover A. J. Biol. Chem. 275:23491-23499(2000) [PubMed: 10807912] [Abstract] Cited for: SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-330, UBIQUITINATION. |
| [9] | "Natural beta-sheet proteins use negative design to avoid edge-to-edge aggregation." Richardson J.S., Richardson D.C. Proc. Natl. Acad. Sci. U.S.A. 99:2754-2759(2002) [PubMed: 11880627] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 204-210. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X01995 Genomic DNA. Translation: CAA26023.1. K02165 Genomic DNA. Translation: AAA45888.1. V01555 Genomic DNA. No translation available. AJ507799 Genomic DNA. Translation: CAD53472.1. | ||||||||||||
| PIR | QQBE50. D43045. | ||||||||||||
| RefSeq | YP_401722.1. NC_007605.1. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | P03230. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-29603N. DIP-43767N. | ||||||||||||
| MINT | MINT-1509916. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| GeneID | 3783750. | ||||||||||||
Phylogenomic databases | |||||||||||||
| ProtClustDB | CLSP2512943. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR007961. Herpes_LMP1. [Graphical view] | ||||||||||||
| Pfam | PF05297. Herpes_LMP1. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Entry information
| Entry name | LMP1_EBVB9 | ||||||||
| Accession | Primary (citable) accession number: P03230 Secondary accession number(s): Q777A4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Viral Protein Annotation Program | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with